These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7564075)
21. Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid. Breborowicz A; Breborowicz M; Oreopoulos DG Am J Nephrol; 2003; 23(6):471-6. PubMed ID: 14605496 [TBL] [Abstract][Full Text] [Related]
22. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells. Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188 [TBL] [Abstract][Full Text] [Related]
23. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products. Breborowicz A; Witowski J; Polubinska A; Pyda M; Oreopoulos D Nephrol Dial Transplant; 2004 Dec; 19(12):3005-11. PubMed ID: 15507476 [TBL] [Abstract][Full Text] [Related]
24. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells. Chang JM; Lin SP; Lai YH; Chen HC Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374 [TBL] [Abstract][Full Text] [Related]
25. Dialysis solutions buffered with lactate or bicarbonate: in vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients. Fougeray S; Slingeneyer A; Bastide JM; Mion C; Bastide M Adv Perit Dial; 1994; 10():235-40. PubMed ID: 7999836 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid. Shimada S; Mori T; Koizumi K; Sato S; Oba-Yabana I; Ohsaki Y; Sato E; Naganuma E; Kurasawa N; Tsuchikawa M; Ito S Adv Perit Dial; 2016; 32():46-50. PubMed ID: 28988589 [TBL] [Abstract][Full Text] [Related]
27. Protective effect of pyruvate upon cultured mesothelial cells exposed to 2 mM hydrogen peroxide. Shostak A; Gotloib L; Kushnier R; Wajsbrot V Nephron; 2000 Apr; 84(4):362-6. PubMed ID: 10754414 [TBL] [Abstract][Full Text] [Related]
28. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]. Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F; BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574 [TBL] [Abstract][Full Text] [Related]
29. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model. Zheng Z; Ye R; Yu X; Bergström J; Lindholm B Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297 [TBL] [Abstract][Full Text] [Related]
30. Sulfotanshinone IIA Sodium Ameliorates Glucose Peritoneal Dialysis Solution-Induced Human Peritoneal Mesothelial Cell Injury via Suppression of ASK1-P38-mediated Oxidative Stress. Zhou Y; He W; Sun W; Zhou Z; Sun M; Xia P; Li W; Zheng M; Zhang L; Ni J; Gao K Cell Physiol Biochem; 2018; 46(6):2434-2444. PubMed ID: 29742502 [TBL] [Abstract][Full Text] [Related]
31. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. Douvdevani A; Rapoport J; Konforti A; Zlotnik M; Chaimovitz C Perit Dial Int; 1993; 13(2):112-7. PubMed ID: 8494931 [TBL] [Abstract][Full Text] [Related]
32. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288 [TBL] [Abstract][Full Text] [Related]
33. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells. Breborowicz A; Pyda M; Moberly J; Martis L; Oreopoulos D Am J Nephrol; 2004; 24(3):316-21. PubMed ID: 15148458 [TBL] [Abstract][Full Text] [Related]
34. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-beta. Medcalf JF; Walls J; Pawluczyk IZ; Harris KP Nephrol Dial Transplant; 2001 Sep; 16(9):1885-92. PubMed ID: 11522874 [TBL] [Abstract][Full Text] [Related]
35. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425 [TBL] [Abstract][Full Text] [Related]
37. Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters. Díaz C; Selgas R; Castro MA; Bajo MA; Fernández de Castro M; Molina S; Jiménez C; Ortiz A; Vara F Adv Perit Dial; 1998; 14():19-24. PubMed ID: 10649684 [TBL] [Abstract][Full Text] [Related]
38. Intracellular glutathione in human peritoneal mesothelial cells exposed in vitro to dialysis fluid. Breborowicz A; Rodela H; Martis L; Oreopoulos DG Int J Artif Organs; 1996 May; 19(5):268-75. PubMed ID: 8791146 [TBL] [Abstract][Full Text] [Related]
39. Antioxidant mechanisms in human peritoneal mesothelial cells (HPMC) exposed in vitro to the constituents of dialysis fluid. Grzybowski AE Med Sci Monit; 2000; 6(2):232-9. PubMed ID: 11208315 [TBL] [Abstract][Full Text] [Related]
40. Effect of dialysate composition on the apoptosis and proliferation of human peritoneal mesothelial cells and protein expression of Fas and c-Myc. Zheng ZH; Ye RG; Bergström J; Lindholm B Adv Perit Dial; 2000; 16():31-5. PubMed ID: 11045257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]